Medicine and Dentistry
Disease
100%
Neoplasm
60%
Systematic Review
53%
Symptom
45%
Quality of Life
45%
Randomized Controlled Trial
41%
Diagnosis
40%
Heart Failure
38%
Malignant Neoplasm
37%
Prevalence
32%
Meta-Analysis
31%
Cohort Analysis
31%
Health Care Cost
30%
Infection
29%
Surgery
27%
Radiation Therapy
26%
Pediatrics
25%
Biological Marker
25%
Drug Therapy
24%
Cardiovascular System
23%
In Vitro
23%
Chronic Obstructive Pulmonary Disease
23%
Positron Emission Tomography
21%
Magnetic Resonance Imaging
21%
Breast Cancer
20%
Asthma
20%
Cardiovascular Disease
20%
Computer Assisted Tomography
20%
Maturity Onset Diabetes of the Young
20%
Diabetes
19%
Injury
19%
Cost-Effectiveness Analysis
19%
Recurrent Disease
19%
Implant
18%
Clinical Trial
18%
COVID-19
18%
Placebo
18%
Hazard Ratio
17%
Chronic Kidney Disease
17%
Odds Ratio
17%
Kidney Function
17%
Overall Survival
16%
Primary Health Care
16%
Positron Emission Tomography
16%
Adverse Event
15%
Atrial Fibrillation
15%
Cross Sectional Study
15%
Liver Transplantation
15%
Epileptic Absence
15%
Childbirth
14%
Positron Emission Tomography-Computed Tomography
14%
Apoplexy
14%
Health Care
13%
Observational Study
13%
Body Mass Index
13%
Kidney Graft
13%
Arm
13%
Clinician
13%
Head and Neck Cancer
12%
Rehabilitation Engineering
12%
Diabetes Mellitus
12%
Metastatic Carcinoma
11%
Glomerular Filtration Rate
11%
Population
11%
Nodular Melanoma
11%
Blood Pressure
11%
Prospective Cohort Study
11%
Urinary System
11%
Nephropathy
11%
Biopsy
11%
Intensive Care Unit
10%
Neck
10%
Bleeding
10%
Prospective Study
10%
Kidney Transplantation
10%
Randomized Clinical Trial
10%
Ovarian Cancer
10%
Transplantation
9%
Non Small Cell Lung Cancer
9%
General Practitioner
9%
Myocardial Infarction
9%
Patient Referral
9%
Surgeon
9%
Medicine
9%
Lung Cancer
9%
Logistic Regression Analysis
9%
Radioactive Tracer
9%
Hemodynamic
9%
Outpatient
9%
Mental Health
9%
Physical Activity
9%
Decision Making
9%
Side Effect
9%
Cohort Effect
9%
Isotopes of Calcium
9%
Prosthesis
8%
Cancer
8%
Cardiovascular Risk
8%
Inflammatory Bowel Disease
8%
Pathophysiology
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
81%
Heart Failure
48%
Neoplasm
40%
Malignant Neoplasm
39%
Symptom
32%
Prevalence
31%
Placebo
30%
Mouse
27%
Asthma
27%
Non Insulin Dependent Diabetes Mellitus
24%
Infection
24%
Randomized Controlled Trial
24%
Cohort Study
24%
Biological Marker
24%
Pharmacokinetics
23%
Inflammation
22%
Chronic Obstructive Lung Disease
22%
Adverse Event
20%
Clinical Trial
18%
Chemotherapy
18%
Cardiovascular Disease
18%
Chronic Kidney Failure
15%
Atrial Fibrillation
14%
Heart Infarction
14%
Receptor
13%
Injury
12%
Side Effect
12%
Recurrent Disease
11%
Vaccination Policy
11%
Overall Survival
11%
Diabetes Mellitus
11%
Creatinine
10%
Breast Cancer
10%
Acute Heart Failure
10%
Non Small Cell Lung Cancer
9%
Kidney Disease
9%
Antibiotics
9%
Epileptic Absence
9%
Normal Human
9%
Remission
9%
Syndrome
8%
Observational Study
8%
Tumor Necrosis Factor
8%
Cytokine
8%
Combination Therapy
8%
Comorbidity
8%
Tracer
8%
Antibiotic Agent
8%
All Cause Mortality
8%
Cardiovascular Risk
8%
Pharmacotherapy
8%
Lung Cancer
7%
Albuminuria
7%
Antiinfective Agent
7%
Prospective Study
7%
Bleeding
7%
Inflammatory Bowel Disease
7%
Prospective Cohort Study
7%
Head and Neck Cancer
7%
Fibrosis
7%
Bile Acid
7%
Pharmacodynamics
6%
Atherosclerosis
6%
Pathophysiology
6%
Dipeptidyl Carboxypeptidase Inhibitor
6%
Parkinson's Disease
6%
HIV
6%
Randomized Clinical Trial
6%
Disease Exacerbation
6%
Cisplatin
6%
Amino Acid
6%
Obesity
6%
Chemoradiation Therapy
6%
Acute Myeloid Leukemia
6%
Liposome
6%
Adverse Drug Reaction
5%
Anticoagulant Agent
5%
Melanoma
5%
Congestive Heart Failure
5%
Coronary Artery Disease
5%
Venous Thromboembolism
5%
Nanoparticle
5%
Clinical Study
5%
Dapagliflozin
5%
Sepsis
5%
C Reactive Protein
5%
Antidepressant
5%
Ovary Cancer
5%
Mouse Model
5%
Cross-Sectional Study
5%
Progression Free Survival
5%
Therapeutic Drug Monitoring
5%
Multiple Sclerosis
5%
Colorectal Cancer
5%
Renin
5%
Epidermal Growth Factor Receptor
5%
Doxorubicin
5%
Acute Heart Infarction
5%
Immunotherapy
5%
Brain Natriuretic Peptide
5%
Keyphrases
Netherlands
36%
Dutch
31%
Confidence Interval
22%
Meta-analysis
17%
Heart Failure
16%
Quality of Life
15%
Type 2 Diabetes Mellitus (T2DM)
13%
Randomized Controlled Trial
12%
Risk Factors
12%
Asthma
11%
Hazard Ratio
11%
Chronic Kidney Disease
10%
Older Adults
9%
Systematic Meta-analysis
9%
Chronic Obstructive Pulmonary Disease
9%
Placebo
8%
High Risk
8%
Depressive Symptoms
8%
Clinical Outcomes
8%
Health-related Quality of Life
8%
Atrial Fibrillation
8%
Cardiovascular Disease
8%
Patients with Heart Failure
8%
Heart Failure with Preserved Ejection Fraction (HFpEF)
8%
Type 2 Diabetic Patients
7%
Odds Ratio
7%
Comorbidity
7%
Cost-effectiveness
7%
Tumor
7%
Primary Care
7%
Diabetes
7%
Cancer Patients
6%
COVID-19
6%
Prospective Cohort Study
6%
Inflammation
6%
Cardiovascular Risk
6%
Clinical Practice
6%
Healthcare Professionals
6%
All-cause Mortality
6%
Physical Activity
6%
Major Depressive Disorder
6%
Overall Survival
6%
Healthy Controls
6%
Estimated Glomerular Filtration Rate
6%
Radiotherapy
6%
Acute Heart Failure
6%
Groningen
5%
Obesity
5%
Inflammatory Bowel Disease
5%
Type 1 Diabetes Mellitus (T1DM)
5%
Clinical Trials
5%
Europe
5%
Body Mass Index
5%
Albuminuria
5%
Head-and-neck Cancer
5%
Positron Emission Tomography
5%
General Practitioners
5%
Attention Deficit Hyperactivity Disorder
5%
Cardiovascular Mortality
5%
Pharmacokinetics
5%
Kidney
5%
Blood Pressure
5%
Anxiety Disorders
5%